Insmed (INSM) Accounts Payables (2010 - 2026)

Insmed's Accounts Payables history runs 17 years deep, the most recent figure standing at $352.6 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 51.52% year-over-year to $352.6 million; the TTM figure through Mar 2026 stood at $352.6 million (up 51.52% YoY), while the FY2025 annual figure was $456.1 million, up 59.9% from the prior year.
• Accounts Payables was $352.6 million for Q1 2026 at Insmed, down from $456.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $456.1 million in Q4 2025 to a low of $31.1 million in Q2 2022.
• Historically, Accounts Payables has averaged $232.0 million across 5 years, with a median of $215.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables grew 0.2% in 2022, then surged 534.64% in 2023.
• A 5-year view of Accounts Payables shows it stood at $182.1 million in 2022, then advanced by 18.05% to $215.0 million in 2023, then soared by 32.66% to $285.2 million in 2024, then surged by 59.9% to $456.1 million in 2025, then retreated by 22.7% to $352.6 million in 2026.
• The last three Accounts Payables figures came in at $352.6 million (Q1 2026), $456.1 million (Q4 2025), and $409.8 million (Q3 2025), per Business Quant data.